Michael J. Peckham

Michael J. Peckham's AcademicInfluence.com Rankings

Michael J. Peckham

Medical

#2865

World Rank

#3308

Historical Rank

Oncology

#188

World Rank

#194

Historical Rank

medical Degrees

Michael J. Peckham

Engineering

#6000

World Rank

#7291

Historical Rank

Biomedical Engineering

#493

World Rank

#503

Historical Rank

Applied Physics

#1856

World Rank

#1888

Historical Rank

engineering Degrees

Download Badge

Medical
Engineering

Why Is Michael J. Peckham Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael J. Peckham's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. (1979) (920)
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. (1984) (490)
HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONE (1987) (367)
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). (1983) (250)
COMBINED MANAGEMENT OF MALIGNANT TERATOMA OF THE TESTIS (1979) (249)
ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURS (1982) (238)
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II (2004) (215)
The evaluation of low dose pre‐operative X‐ray therapy in the management of operable rectal cancer; results of a randomly controlled trial (1984) (205)
The response to chemotherapy of a variety of human tumour xenografts. (1983) (188)
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. (1978) (182)
Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy. (1986) (174)
Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. (1983) (151)
Advanced seminoma: treatment with cis-platinum-based combination chemotherapy or carboplatin (JM8). (1985) (135)
Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. (1984) (132)
The management of metastatic seminoma testis (1982) (130)
Radiotherapy for stage I seminoma testis: results of treatment and complications. (1986) (121)
Glioblastoma Multiforme: A Controlled Trial to Assess the Value of Specific Active Immunotherapy in Patients Treated by Radical Surgery and Radiotherapy (1973) (113)
Reproductive and endocrine function in patients with Hodgkin's disease: effects of oophoropexy and irradiation. (1976) (112)
Extranodal non‐Hodgkin's lymphoma presenting in the testicle. A clinical and pathologic study of 24 cases (1980) (106)
PROGNOSTIC FACTORS IN ADVANCED NON-SEMINOMATOUS GERM-CELL TESTICULAR TUMOURS: RESULTS OF A MULTICENTRE STUDY Report from the Medical Research Council Working Party on Testicular Tumours (1985) (106)
VP16-213 as a single agent in advanced testicular tumors. (1980) (105)
Para-aortic lymphadenectomy after chemotherapy for metastatic non-seminomatous germ cell tumours: prognostic value and therapeutic benefit. (1993) (104)
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. (1991) (104)
Orchidectomy alone for stage I seminoma of the testis (1990) (102)
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease. (1977) (96)
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin. (1989) (94)
The radiobiology of human neuroblastoma. (1985) (87)
Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. (1991) (82)
Proliferation characteristics of the various classes of cells in Hodgkin's disease (1969) (79)
Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumours. (1989) (78)
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. (1981) (78)
CHILDREN FATHERED BY MEN TREATED FOR TESTICULAR CANCER (1985) (77)
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. (1978) (76)
In vitro radiation response of cells from four human tumors propagated in immune-suppressed mice. (1978) (73)
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. (1983) (72)
Cell proliferation in human malignant lymphomas. Analysis of labelling index and DNA content in cell populations obtained by biopsy. (1968) (68)
The response of lymph node metastases of testicular teratoma to radiation therapy. (1976) (66)
Bilateral germ cell tumours of the testis. (1980) (62)
SERUM-ALPHA1-FETOPROTEIN IN PATIENTS WITH TESTICULAR TUMOURS (1976) (61)
Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis. (1987) (59)
Clinical stage II non-seminomatous germ cell testicular tumours. Results of management by primary chemotherapy. (1985) (58)
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft (1976) (58)
CT estimations of mean attenuation values and volume in testicular tumors: a comparison with surgical and histologic findings. (1982) (58)
The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. (1980) (57)
Combined radiotherapy--chemotherapy of Lewis lung carcinoma. (1978) (55)
The investigation and management of Hodgkin's disease in the pregnant patient (1976) (55)
Surveillance after orchiectomy for stage I seminoma of the testis. (1987) (54)
The human tumour xenograft—a valid model in experimental chemotherapy? (1980) (53)
Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. (1980) (52)
Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis. (1982) (50)
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069. (1986) (48)
Lung damage in C57B1 mice following thoracic irradiation: enhancement by chemotherapy. (1979) (47)
"Bad risk" non-Hodgkin lymphomas. (1983) (47)
Results of radiotherapy for stage II testicular seminoma. (1986) (45)
Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis. (1986) (44)
Elevated serum alphafetoprotein and seminoma clinical evidence for a histologic continuum? (1982) (44)
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease. (1982) (44)
Mediastinal involvement in early-stage Hodgkin's disease. Response to treatment and pattern of relapse. (1980) (43)
Elective delayed excision of bulky para-aortic lymph node metastases in advanced non-seminoma germ cell tumours of testis. (1981) (42)
The role of computed tomography in the management of testicular teratoma. (1979) (42)
In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids. (1982) (41)
Chemotherapy of germ-cell ovarian tumours: first-line treatment with etoposide, bleomycin and cisplatin or carboplatin. (1987) (41)
PRESERVATION OF OVARIAN FUNCTION IN PATIENTS REQUIRING RADIOTHERAPY FOR PARA-AORTIC AND PELVIC HODGKIN'S DISEASE (1972) (40)
Assays of drug sensitivity for cells from human tumours: in vitro and in vivo tests on a xenografted tumour. (1979) (39)
Placental alkaline phosphatase as a tumour marker in seminoma using the H17 E2 monoclonal antibody assay. (1985) (39)
Accuracy of grey-scale ultrasonography of liver and spleen in Hodgkin's disease and the other lymphomas compared with isotope scans. (1977) (38)
Survival in localized nodal and extranodal non-Hodgkin's lymphomata. (1975) (38)
Human tumour xenografts: a critical appraisal. (1980) (38)
The Management of testicular tumours (1981) (38)
cis-Diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary report. (1985) (37)
An analysis of prognostic factors in early stage Hodgkin's disease. (1986) (37)
The pattern of cell growth in reticulum cell sarcoma and lymphosarcoma. (1970) (37)
Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer. (1986) (36)
Radiotherapy of testicular tumours. (1974) (34)
Clinical presentation as a predictor of laparotomy findings in supradiaphragmatic stage I and II Hodgkin's disease. (1986) (34)
Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma. (1985) (33)
The quantitative response of human tumours to radiation and misonidazole. (1979) (33)
Colony growth and clonogenic cell survival in human melanoma xenografts treated with chemotherapy. (1980) (33)
The results of radiotherapy for Hodgkins' disease. (1975) (33)
A human testicular teratoma serially transplanted in immune-deprived mice. (1979) (32)
The role of surgery in the combined management of metastases from malignant teratomas of testis. (1980) (32)
The changing role of staging laparotomy in Hodgkin's disease: A personal series of 310 patients (1982) (32)
Hypothesis: when is a seminoma not a seminoma? (1981) (31)
Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement. (1987) (31)
The significance of scrotal interference in stage I testicular cancer managed by orchiectomy and surveillance. (1986) (31)
Evaluation of Computed Tomography in the Management of Testicular Teratoma (1981) (31)
Bulky mediastinal Hodgkin's disease management and prognosis (1984) (31)
Surveillance following orchidectomy for stage I testicular cancer. (1987) (31)
The role of abdominal computed tomography in the management of testicular tumours. (1980) (30)
Serum tumour marker regression rate following chemotherapy for malignant teratoma. (1984) (30)
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease. (1979) (30)
Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers. (1979) (29)
Occult germ-cell testicular tumours. (1983) (29)
Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 mice. (1979) (29)
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. (1980) (27)
Value of gallium scanning in seminoma of the testis. (1976) (27)
Infradiaphragmatic presentation of Hodgkin's disease. (1981) (26)
Second malignancies and Hodgkin's disease--the Royal Marsden Hospital experience. (1988) (26)
Radiosensitivity of the acute leukaemic infiltrate. (1976) (26)
The role of surgery in the combined management of metastases from malignant teratomas of testis. (1980) (25)
Intracardiac metastases from malignant teratoma of the testis. (1986) (25)
The management of advanced testicular teratoma. (1988) (24)
Combination chemotherapy in advanced and recurrent Hodgkin's disease. (1973) (23)
The role of ultrasound in the assessment and treatment of abdominal metastases from testicular tumours. (1977) (23)
The accuracy of lymphography in Hodgkin's disease. (1974) (22)
Hodgkin's Disease in Children (1977) (22)
Abdominal relapse in stage 1 nonseminomatous germ cell tumours of the testis managed by surveillance or with adjuvant chemotherapy (2000) (22)
8 - Testicular tumours (1975) (21)
Alcohol pain in Hodgkin's disease (1976) (21)
A comparison of the chemosensitivity of a primary tumour and its metastases using a human tumour xenograft. (1979) (20)
Cell kinetics in reticulum cell sarcoma (1972) (20)
Total body irradiation in advanced non-Hodgkin's lymphoma. (1981) (20)
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease. Reversal with chemotherapy (1976) (17)
Chemotherapy and radiotherapy for advanced testicular nonseminoma (1983) (17)
Influence of tumour size on radiosensitization by misonidazole. (1978) (17)
Experimental combination and single-agent chemotherapy in human lung-tumour xenografts. (1982) (16)
Evaluation of computed tomography in the management of testicular teratoma. (1981) (16)
Computed Tomography in Testicular Disease: A Review (1981) (16)
The therapeutic response of human tumour xenografts (1980) (15)
The response of human tumour metastases to radiation and misonidazole. (1978) (15)
Radiation therapy of the non-Hodgkin's lymphomas. (1974) (15)
Stage III Hodgkin's disease--long-term results following chemotherapy, radiotherapy and combined modality therapy. (1989) (15)
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy. (1976) (15)
RENAL DAMAGE AFTER CIS-PLATINUM (1979) (15)
Encephalopathy following bone marrow transplantation. (1977) (14)
The accuracy of CT scanning prior to para-aortic lymphadenectomy in patients with bulky metastases from testicular teratoma. (1985) (13)
Limitations of the human tumour xenograft system in individual patient drug sensitivity testing. (1984) (13)
Letter: Treatment of Hodgkin's disease. (1974) (13)
Human Tumour Xenografts in Anticancer Drug Development (1988) (13)
Thymolipoma in association with Hodgkin's disease. (1985) (13)
Total-body irradiation in advanced non-Hodgkin's lymphoma. (1977) (13)
Chemotherapy and radiotherapy in advanced testicular non-seminoma. 2. Results of treatment. (1984) (12)
Treatment of favorable-prognosis nonseminomatous testicular germ cell tumors with etoposide, cisplatin, and reduced dose of bleomycin. (1987) (12)
Chemotherapy and radiotherapy for advanced testicular non-seminoma. I. The influence of sequence and timing of drugs and radiation on the appearance of normal tissue damage. (1983) (12)
Preservation of ovarian function in patients requiring radiotherapy for para-aortic and pelvic Hodgkin's disease. (1972) (11)
The recovery of iron uptake in erythropoietic bone marrow following large field radiotherapy. (1979) (11)
Medical options in the management of stages 1 and 2 (N0-N3, M0) testicular germ cell tumors. (1987) (11)
Etoposide as a single agent in relapsed advanced lymphomas (1982) (11)
The combination of 5-fluorouracil with misonidazole in patients with advanced colorectal cancer. (1982) (11)
Quantitative Cytology and Cytochemistry of Hodgkin's Tissue Labelled in vivo with Tritiated Thymidine (1973) (11)
Prognosis following chemotherapy for metastatic malignant teratoma. (1987) (10)
Surveillance after orchidectomy for clinical stage I germ-cell tumours of the testis. (1988) (10)
Infradiaphragmatic Hodgkin's disease. (1992) (10)
Cell proliferation in Hodgkin's disease. (1973) (9)
Changes in lymph node size following systemic irradiation for malignant lymphoma. (1979) (9)
The response of chronic lymphocytic leukemia to treatment by extracorporeal irradiation of the blood, assessed by isotope-labeling procedures. (1970) (9)
Therapeutic irradiation of the central nervous system using intrathecal 90Y--DTA. (1976) (8)
Chemotherapy of primary (in situ) testicular tumours: response in advanced metastatic disease. (1983) (8)
Hodgkin's disease during surveillance of stage I testicular teratoma. (1986) (8)
The detection and localisation of abdominal lymph node metastases from testicular teratomas. (1977) (7)
Combination chemotherapy for testicular tumours. (1974) (7)
Experimental germ-cell tumors. (1980) (7)
Aetiologic leads in the malignant lymphomas (1974) (6)
Clinical objectives and normal tissue responses in combined chemotherapy and radiotherapy. (1981) (6)
An appraisal of the role of radiation therapy in the management of nonseminomatous germ-cell tumors of the testis in the era of effective chemotherapy. (1979) (6)
CT Scanning and the Surgery of Metastatic Teratoma of the Testis: a Preliminary Report (1978) (5)
Methotrexate for relapse of metastatic non-seminomatous germ-cell tumours (1987) (5)
The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease. (1977) (5)
Clinico-pathological features of prognostic significance in operable rectal cancer in 17 centres in the U.K. (Third report of the M.R.C. Trial, on behalf of the Working Party). (1984) (4)
The Therapeutic Response of a Variety of Human Tumour Xenografts (1988) (4)
Experimental chemotherapy of gastrointestinal carcinoma xenografts. (1979) (4)
THE EFFECT OF X‐IRRADIATION ON THE NUMBERS OF SUPRABASAL DENDRITIC CELLS IN HUMAN EPIDERMIS. (1966) (4)
Populations of Exposure to Low Levels of Ionizing Radiations (Committee on the Biological Effects of Ionizing Radiations (1986) (4)
FAILURE OF METHYL-C.C.N.U. AND 5-FLUOROURACIL IN COLORECTAL CANCER (1978) (3)
HUMAN TUMOURS IN MICE AND RATS (1978) (3)
Combination of Chemotherapy and Radiotherapy in the Treatment of Testicular Cancer (1980) (2)
Mediastinal Hodgkin's disease (1984) (2)
Staging laparotomy in the non-Hodgkin's lymphomas; reappraisal after five year follow-up. (1984) (2)
Postchemotherapy staging laparotomy in Hodgkin's disease. (1982) (2)
Lymphocyte transformation in chronic lymphocytic leukaemia. (1972) (2)
Changes in the size of pelvic lymph nodes in patients being followed after radiotherapy for Hodgkin's disease. (1980) (1)
Blood and neoplastic diseases. Management of solid tumours-surgery, radiotherapy, and chemotherapy. (1974) (1)
PLACE OF RADICAL NODE DISSECTION IN TESTICULAR TUMOUR THERAPY (1982) (1)
Surveillance following orchiectomy for clinicaL stage I testicular germ-cell malignancy. (1985) (1)
The Clinical Value of Alpha‐fetoprotein and Human Chorionic Gonadotrophin as Tumour Markers in Patients with Teratoma of the Testis (1978) (1)
Current concepts of the management of Hodgkin's disease, with particular reference to intrathoracic involvement. (1972) (1)
[The lymphocyte populations in chronic lymphoid leukemia and their response to splenic irradiation]. (1968) (1)
Comparison of the chemosensitivity of bronchial carcinoma xenografts with donor patients. Abstr. (1980) (1)
Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy. (1985) (1)
Radiotherapy in Modern Clinical Practice (1976) (1)
Etoposide (VP 16–213) as a Fourth Drug in Combination with BVP for Treating Metastatic Germ Cell Tumours (1984) (1)
Orchidectomy for clinical stage I testicular cancer: progress report of the Royal Marsden Hospital Study. (1985) (1)
Blood and neoplastic diseases. Solid tumours. (1974) (0)
CT IN TESTICULAR TERATOMAS (1978) (0)
P10.02: Interdisciplinary approach to medical management of a subhepatic ectopic pregnancy (2015) (0)
Radiotherapy and Chemotherapy for Colorectal Cancer [Abridged] (1973) (0)
Invited discussion: Value of radiogallium scanning in Hodgkin's disease. (1973) (0)
Epidemiology and clinicopathological aspects of pre-malignant and malignant lesions. (1995) (0)
Surveillance after orchidectomy for clinical stage I testicular non-seminoma. (1984) (0)
The non-Hodgkin's lymphomas. (1975) (0)
Bronchial Carcinoma (1930) (0)
The Biology and Clinical Management of Bladder Cancer. Ed. by E. H. Cooper and R. E. Williams. Published by Blackwell Scientific Publications. Pp. 293. Price £9.75. (1975) (0)
Therapeutic irradiation of the liver. (1972) (0)
Book reviewLa Maladie de Hodgkin. By LagardeC., ChauvergneJ. and HoerniB., pp. vi + 150 (illus.), 1971 (Paris, Masson & Cie), 60F. (1972) (0)
Invited discussion: Tumor-associated antigen in Hodgkin's disease. (1973) (0)
Obstacles to the improvement of radiotherapy of rectal cancer. (1973) (0)
Concluding remarks. (2018) (0)
Chairman's summary of Section IV. Assays using biopsies or marker proteins (1980) (0)
CT scanning and the surgery of metastatic teratoma of the testis: a preliminary report. (1979) (0)
L'Evolution des Cancers (1978) (0)
The Cell Cycle in Malignancy and Immunity. Published by U.S. Energy Research and Development Administration. National Technical Information Service, Springfield, Va. Pp. 618. Price $16.10. (1975) (0)
Combined chemotherapy-radiotherapy for the non-Hodgkin lymphomas. (1978) (0)
New Aspects of Breast Cancer. Vol. 1. Host Defence in Breast Cancer. Ed. by Basil A. Stoll. Published by Heinemann. Pp. 206. Price £3.20. (1975) (0)
Recent Advances in Detection and Treatment of Urological (1974) (0)
Implications of scrotal interference (1978) (0)
Replay to letter by Drs Gillis and Hole (1982) (0)
Recent Advances in Detection and Treatment of Urological (1974) (0)
Frontiers of Radiation Therapy and Oncology, Vol. 9. The Relationship of Histology to Cancer Treatment (1975) (0)
The potential role of xenografts in the investigation of the clonal structure of human tumours (1980) (0)
EJC expands: Oral oncology (1991) (0)
Testicular tumours. (1975) (0)
TREATMENT OF TESTICULAR TUMOURS (1983) (0)
Medicine and Books (1986) (0)
Three dimensions Cell and molecular oncology clinical oncology epidemiology (1991) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Michael J. Peckham?

Michael J. Peckham is affiliated with the following schools:

Michael J. Peckham's Academic­Influence.com Rankings

Why Is Michael J. Peckham Influential?

Michael J. Peckham's Published Works

Published Works

What Schools Are Affiliated With Michael J. Peckham?

Michael J. Peckham's AcademicInfluence.com Rankings